Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, December 9 at 2:00 PM ET

Register Free →

This Subcontract opportunity from Department Of Defense was posted on July 12, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Pharmaceutical Manufacturing and Supply of Sumatriptan Succinate Tablets

Closed
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The contract entails the manufacture and supply of Sumatriptan Succinate Tablets, 100mg, packaged in bottles of nine units, adhering strictly to FDA regulations, current Good Manufacturing Practices, and Department of Defense Logistics Agency technical specifications for packaging, labeling, and storage conditions. The product must remain stable and compliant under controlled room temperature storage of 20–25°C, ensuring pharmacological integrity and regulatory conformity throughout the supply chain. All manufacturing processes, quality controls, and documentation are required to meet the stringent standards mandated by federal and military pharmaceutical guidelines. Performance is to be carried out in support of the Department of Defense, specifically through the Medical Supply Chain Pharm FSA, with the place of performance listed as APO 09094-3219. The contract is structured as a subcontract under NAICS code 325412, indicating its classification within pharmaceutical and medicine manufacturing. The solicitation was posted on July 12, 2026, with a response deadline of July 20, 2026, leaving a limited window for qualified suppliers to submit proposals. The contract is governed by Defense Logistics Agency procurement protocols and is accessible via the DIBBS platform for authorized bidders seeking to fulfill this critical medical supply requirement for U.S. military healthcare operations.

General Info

Manufacture and supply of 100mg Sumatriptan Succinate Tablets per DoD and FDA standards for military use.

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

APO, AE, 09094-3219, USA

Set-Aside

NONE

Documents

This scope was carved out of SPE2DP-26-T-4080.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

SUMATRIPTAN SUCCINATE

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseClosed
Posted

subcontract

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
ContactsNo contacts available
OfficeN/A
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Manufacture and supply of Sumatriptan Succinate Tablets, 100mg, in bottles of 9, meeting FDA, cGMP, and DLA technical specifications including packaging, labeling, and storage at 20–25°C.

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS